Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Europe Finance Weekly.
Press releases published on March 24, 2025

Univest Securities, LLC Announces Closing of $1.48 Million Registered Direct Offering for its Client PMGC Holdings Inc. (NASDAQ: ELAB)
New York, New York, March 24, 2025 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of registered direct …

Helium Evolution Provides Update on 5-30 and 10-36 Wells
CALGARY, Alberta, March 24, 2025 (GLOBE NEWSWIRE) -- Helium Evolution Incorporated (TSXV:HEVI) ("HEVI" or the "Company"), a Canadian-based helium exploration company focused on developing assets in southern Saskatchewan, is pleased to provide an update on …

Urgently Notified By Nasdaq Of Non-Compliance With Nasdaq’s Continued Listing Standards
VIENNA, Va., March 24, 2025 (GLOBE NEWSWIRE) -- Urgent.ly Inc. (Nasdaq: ULY) (“Urgently”), a U.S.-based leading provider of digital roadside and mobility assistance technology and services, announced today that The Nasdaq Stock Market LLC (“Nasdaq”) …

Trump Media Announces Intention to Partner with Crypto.com to Launch ETFs
America-First Investment Funds Slated to Launch in 2025 SARASOTA, Fla., March 24, 2025 (GLOBE NEWSWIRE) -- Trump Media and Technology Group Corp. (Nasdaq: DJT) ("TMTG" or the "Company"), operator of the social media platform Truth Social, the streaming …

Ninepoint Partners Announces Estimated March 2025 Cash Distributions for Ninepoint Cash Management Fund - ETF Series
TORONTO, March 24, 2025 (GLOBE NEWSWIRE) -- Ninepoint Partners LP (“Ninepoint Partners”) today announced the estimated March 2025 cash distribution for the ETF Series of Ninepoint Cash Management Fund (the “Fund”). Ninepoint Partners expects to issue a …

Power Solutions International Announces Record Fourth Quarter and Record Full Year 2024 Financial Results
Quarter Sales of $144.3 million, up 38% from a year earlier, Full Year Sales of $476.0 million, up 4% from a year earlier, Quarter Net Income of $23.3 million, up 178% from a year earlier, EPS $1.01 for the Quarter, Full Year Net Income of $69.3 million, …

iAnthus Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results
NEW YORK and TORONTO, March 24, 2025 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN, OTCQB: ITHUF), which owns, operates, and partners with regulated cannabis operations across the United States, today reported …

Black Hills Corp. Electric Utility Receives Approval for New Rates in Colorado
RAPID CITY, S.D., March 24, 2025 (GLOBE NEWSWIRE) -- Black Hills Corp. (NYSE: BKH) today announced that its electric utility subsidiary in Colorado received approval from the Colorado Public Utilities Commission for new rates. The approved new rates will …

Satellogic Reports 2024 Financial Results and Business Update
Revenue up 28% to $12.9 million in 2024 Redomicile to U.S. Nears Completion; Set to Accelerate Market Opportunities Completed $10 Million Private Placement Entered into $50 Million At-The-Market (ATM) Program NEW YORK, March 24, 2025 (GLOBE NEWSWIRE) -- …

Beyond Oil Announces Start of Commercialization of India Distribution Agreement; First Payment Received
VANCOUVER, BC and KIBBUTZ YIFAT, Israel, March 24, 2025 (GLOBE NEWSWIRE) -- Beyond Oil Ltd. (CSE: BOIL) (OTCQB: BEOLF) (Frankfurt: UH9) (“Beyond Oil” or the “Company”), a food-tech innovation company dedicated to reducing health risks associated with fried …

Rainbow Realty Group Completes $12 Million Senior Real Estate Mortgage Loan to Verano Holdings Corp
NEW YORK, March 24, 2025 (GLOBE NEWSWIRE) -- Rainbow Realty Group IV, LLC ("Rainbow"), in collaboration with Rainbow Realty Group II, LLC, and MJ Real Estate Investment Trust ("MJ REIT"), has successfully closed a $12 million cross-collateralized senior …

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
BDC-4182 on track to start a clinical trial in gastric cancer in second quarter 2025 BDC-3042 Phase 1 clinical trial fully enrolled the highest dose cohort with no dose-limiting toxicities (DLTs), results will be reported in second quarter 2025 Cash …

RedCloud Holdings Announces Closing of $20 Million Initial Public Offering
LONDON, March 24, 2025 (GLOBE NEWSWIRE) -- RedCloud Holdings plc (“RedCloud” or the “Company”), today announced the closing of its initial public offering of 4,444,445 of its ordinary shares at a public offering price of $4.50 per share (the “Offering”). …

Prairie Operating Co. Announces Registered Direct Offering of Series F Convertible Preferred Stock and Warrants to Purchase Common Stock
HOUSTON, March 24, 2025 (GLOBE NEWSWIRE) -- Prairie Operating Co. (“Prairie,” the “Company,” “we” or “our”) (Nasdaq: PROP), an independent oil and gas company focused on the acquisition and development of crude oil, natural gas and natural gas liquids, …

Parsons’ Board Approves $250 Million Share Repurchase Authorization
CHANTILLY, Va., March 24, 2025 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that its board of directors has increased the company’s stock repurchase authorization to $250 million. “Parsons’ strong operating results and cash flow …

Artiva Biotherapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights
Initial data for AlloNK® from autoimmune program expected H1 2025 Updated clinical data from Phase 1/2 trial exploring AlloNK + rituximab in NHL showing continued durability of response to be presented at a medical conference in 2025 Strengthened key …

NeuroNOS Secures $2.0 Million in Funding to Advance Development of an Innovative Autism Therapy
First-in-human studies anticipated to begin in 2026 Engaged a top tier U.S. based contract manufacturer to ensure the highest standards of quality Currently in the advanced stages of formulation development for subcutaneous injection, with plans for an …

AEON Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
– Initiated analytical studies in Q4 2024 to prepare for a potential Biosimilar Biological Product Development (“BPD”) Type 2a meeting with the FDA in the second half of 2025 – – Pursuing a 351(k) regulatory pathway for ABP-450, which offers potential …

Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts
Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 million GraftAssure RUO assay launched July 2024 Signed strategic partner and investor, Bio-Rad Laboratories Fully funded clinical kitted product development with $50+ million in …

Dragonfly Energy Reports Fourth Quarter and Full Year 2024 Results
Fourth Quarter Revenue Growth of 17% Led by Significant OEM Growth Debt Restructuring and Concurrent Capital Raise Enhance Financial Position and Liquidity Initiates Corporate Optimization Program Guides to First Quarter 2025 Net Sales of Approximately $13 …